Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	positive regulation of protein localization to centrosome	APC PARD6A MARK4	9.00e-06	7	133	3	GO:1904781
GeneOntologyBiologicalProcess	protein localization to cytoskeleton	MAP1A APC FAM83H PARD6A MARK4	5.38e-05	63	133	5	GO:0044380
GeneOntologyBiologicalProcess	regulation of protein localization to centrosome	APC PARD6A MARK4	5.53e-05	12	133	3	GO:1904779
GeneOntologyCellularComponent	anchoring junction	ILDR2 SHROOM3 SYNM APC CCDC85C MAST2 CCDC85A GJD4 MPRIP PLEKHG4B CCDC88C FNDC1 DLC1 AJAP1 PTPRJ PARD6A PCDHGA12 SSH2 BCAR3 BAIAP2L2	4.62e-06	976	135	20	GO:0070161
GeneOntologyCellularComponent	cell-cell junction	ILDR2 SHROOM3 SYNM APC CCDC85C CCDC85A GJD4 PLEKHG4B CCDC88C FNDC1 AJAP1 PTPRJ PARD6A PCDHGA12 BAIAP2L2	6.66e-06	591	135	15	GO:0005911
GeneOntologyCellularComponent	postsynaptic density	DRP2 MAP1A CRTC1 GRIN2C CELSR3 LZTS1 LRP4 BSN MAPK8IP2 CAP2 CPEB1	1.70e-04	451	135	11	GO:0014069
GeneOntologyCellularComponent	asymmetric synapse	DRP2 MAP1A CRTC1 GRIN2C CELSR3 LZTS1 LRP4 BSN MAPK8IP2 CAP2 CPEB1	2.75e-04	477	135	11	GO:0032279
GeneOntologyCellularComponent	postsynaptic specialization	DRP2 MAP1A CRTC1 GRIN2C CELSR3 LZTS1 LRP4 BSN MAPK8IP2 CAP2 CPEB1	4.30e-04	503	135	11	GO:0099572
GeneOntologyCellularComponent	apical junction complex	ILDR2 SHROOM3 APC CCDC85C CCDC88C PARD6A	5.71e-04	158	135	6	GO:0043296
GeneOntologyCellularComponent	neuron to neuron synapse	DRP2 MAP1A CRTC1 GRIN2C CELSR3 LZTS1 LRP4 BSN MAPK8IP2 CAP2 CPEB1	5.94e-04	523	135	11	GO:0098984
GeneOntologyCellularComponent	postsynapse	ERBB3 DRP2 MAP1A APC CRTC1 S1PR2 GRIN2C RGS10 CELSR3 LZTS1 LRP4 BSN MAPK8IP2 CAP2 CPEB1 AGAP2	8.90e-04	1018	135	16	GO:0098794
GeneOntologyCellularComponent	somatodendritic compartment	JPH4 DRP2 MAP1A APC CRTC1 RGS10 TIAM2 MAP1S PARD6A LZTS1 MARK4 LRP4 BSN HCFC1 MAPK8IP2 VTI1B CPEB1 AGAP2	9.41e-04	1228	135	18	GO:0036477
GeneOntologyCellularComponent	cell body	DRP2 MAP1A APC CRTC1 RGS10 TIAM2 MAP1S PARD6A LZTS1 LRP4 BSN HCFC1 MAPK8IP2 VTI1B CPEB1	9.91e-04	929	135	15	GO:0044297
GeneOntologyCellularComponent	neuronal cell body	DRP2 MAP1A APC CRTC1 RGS10 TIAM2 MAP1S PARD6A LRP4 BSN HCFC1 MAPK8IP2 VTI1B CPEB1	1.03e-03	835	135	14	GO:0043025
GeneOntologyCellularComponent	dendrite	JPH4 DRP2 MAP1A APC CRTC1 RGS10 MAP1S LZTS1 MARK4 LRP4 BSN HCFC1 CPEB1 AGAP2	1.33e-03	858	135	14	GO:0030425
GeneOntologyCellularComponent	dendritic tree	JPH4 DRP2 MAP1A APC CRTC1 RGS10 MAP1S LZTS1 MARK4 LRP4 BSN HCFC1 CPEB1 AGAP2	1.36e-03	860	135	14	GO:0097447
MousePheno	abnormal mammary gland bud morphology	TBX3 GLI3 LRP4	5.08e-06	5	113	3	MP:0013785
MousePheno	abnormal mammary gland morphology	TBX3 ERBB3 APC FAM83H LZTS1 GLI3 RNFT1 LRP4 AGAP2	3.61e-05	201	113	9	MP:0000627
MousePheno	abnormal apocrine gland morphology	TBX3 ERBB3 APC FAM83H LZTS1 GLI3 RNFT1 LRP4 AGAP2	3.61e-05	201	113	9	MP:0013554
MousePheno	abnormal mammary gland embryonic development	TBX3 GLI3 LRP4	5.92e-05	10	113	3	MP:0004135
Domain	PDZ	SHROOM3 PDZD7 MAST2 TIAM2 PARD6A FRMPD3 MAST3	6.47e-05	141	132	7	PF00595
Domain	PDZ	SHROOM3 PDZD7 MAST2 TIAM2 PARD6A FRMPD3 MAST3	8.78e-05	148	132	7	SM00228
Domain	-	SHROOM3 PDZD7 MAST2 TIAM2 PARD6A FRMPD3 MAST3	9.55e-05	150	132	7	2.30.42.10
Domain	PDZ	SHROOM3 PDZD7 MAST2 TIAM2 PARD6A FRMPD3 MAST3	9.96e-05	151	132	7	PS50106
Domain	PDZ	SHROOM3 PDZD7 MAST2 TIAM2 PARD6A FRMPD3 MAST3	1.04e-04	152	132	7	IPR001478
Domain	CCDC85	CCDC85C CCDC85A	1.48e-04	3	132	2	IPR019359
Domain	CCDC85	CCDC85C CCDC85A	1.48e-04	3	132	2	PF10226
Domain	MAP1	MAP1A MAP1S	1.48e-04	3	132	2	IPR026074
Domain	DUF1908	MAST2 MAST3	2.95e-04	4	132	2	PF08926
Domain	MA_Ser/Thr_Kinase_dom	MAST2 MAST3	2.95e-04	4	132	2	IPR015022
Domain	MAST_pre-PK_dom	MAST2 MAST3	2.95e-04	4	132	2	IPR023142
Domain	-	MAST2 MAST3	2.95e-04	4	132	2	1.20.1480.20
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	VWA5B2 ATMIN SHROOM3 MYCBP2 PPRC1 SLCO4A1 GTF2IRD1 MAST2 MXD4 TIAM2 FAM83H TRIM7 MPRIP CCDC88C EIF4ENIF1 CELSR3 MAP1S CDK13 MARK4 LRP4 HCFC1 IL4R	3.70e-10	1105	136	22	35748872
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	NELFE SHROOM3 MYCBP2 RIPK2 APC CCDC85C CRTC1 MAP7 MAST2 FAM83H MPRIP CCDC88C DLC1 MARK4 MAP3K9 OSBPL10 LIMCH1 SSH2 VCPIP1	1.24e-09	861	136	19	36931259
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	TBX3 MAP1A MMP21 MECOM BUD13 MAP7 MAST2 GJD4 FAM83H TUBGCP6 HOXA9 EIF4ENIF1 CBY2 GLI3 BRPF1 MARK4 LRP4 HAX1 KDM1B	7.83e-08	1116	136	19	31753913
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	ERBB3 MYCBP2 BUD13 DIDO1 CRTC1 MAP7 MAST2 CELSR3 MAP1S CDK13 CPSF7	1.98e-07	361	136	11	26167880
Pubmed	Prediction of the coding sequences of unidentified human genes. XX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	JPH4 WAC FNDC1 CDK13 MARK4 FRMPD3 VCPIP1	2.25e-07	107	136	7	11347906
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	ERBB3 MYCBP2 SYNM PPRC1 APC CCDC85A WAC MPRIP PLEKHH1 MIA2 CELSR3 MAP1S LRP4 CERCAM MAPK8IP2 CAP2 ECE2 AGAP2 VCPIP1	6.70e-07	1285	136	19	35914814
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	NELFE MYCBP2 SLCO4A1 BUD13 DIDO1 GTF2IRD1 TUBGCP6 PACS1 MAP1S CDK13 BRPF1 LIMCH1 MN1 VCPIP1	2.26e-06	774	136	14	15302935
Pubmed	A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase.	APC GTF2IRD1 MAST2 FAM83H EIF4ENIF1 MAP1S GLI3 MAPK8IP2	3.93e-06	232	136	8	25515538
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	SHROOM3 MYCBP2 RIPK2 APC DIDO1 MPRIP CCDC88C LZTS1 LIMCH1 SSH2 FRMPD3 BSN MAPK8IP2 CAP2 AGAP2	5.94e-06	963	136	15	28671696
Pubmed	The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.	SYNM APC DIDO1 MAP7 EIF4ENIF1 LIMCH1 HCFC1 VCPIP1	8.08e-06	256	136	8	33397691
Pubmed	Substrate trapping proteomics reveals targets of the βTrCP2/FBXW11 ubiquitin ligase.	PABPC4 MAST2 TUBGCP6 MAP1S HCFC1 MAST3	1.17e-05	128	136	6	25332235
Pubmed	Muscle mTORC1 suppression by IL-6 during cancer cachexia: a role for AMPK.	APC CRTC1	1.52e-05	2	136	2	23531613
Pubmed	Dominant negative interference of transcription factor AP-2 causes inhibition of ErbB-3 expression and suppresses malignant cell growth.	ERBB3 TFAP2C	1.52e-05	2	136	2	11859873
Pubmed	Fusobacterium nucleatum Promotes Metastasis in Colorectal Cancer by Activating Autophagy Signaling via the Upregulation of CARD3 Expression.	RIPK2 APC	1.52e-05	2	136	2	31903123
Pubmed	Variants in HCFC1 and MN1 genes causing intellectual disability in two Pakistani families.	MN1 HCFC1	1.52e-05	2	136	2	38956580
Pubmed	PGC-1β promotes enterocyte lifespan and tumorigenesis in the intestine.	APC PPARGC1B	1.52e-05	2	136	2	25288742
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	TMEM201 SHROOM3 APC CCDC85C CRTC1 MAST2 FAM83H CCDC88C EIF4ENIF1 BRPF1 NFKBIE CEP135 VCPIP1	3.21e-05	853	136	13	28718761
Pubmed	Regulation of Tbx3 expression by anteroposterior signalling in vertebrate limb development.	TBX3 GLI3	4.54e-05	3	136	2	12376101
Pubmed	New insights into PGC-1 coactivators: redefining their role in the regulation of mitochondrial function and beyond.	PPRC1 PPARGC1B	4.54e-05	3	136	2	25495651
Pubmed	Cenani-Lenz syndrome and other related syndactyly disorders due to variants in LRP4, GREM1/FMN1, and APC: Insight into the pathogenesis and the relationship to polyposis through the WNT and BMP antagonistic pathways.	APC LRP4	4.54e-05	3	136	2	30569497
Pubmed	PGC-1-related coactivator complexes with HCF-1 and NRF-2beta in mediating NRF-2(GABP)-dependent respiratory gene expression.	PPRC1 HCFC1	4.54e-05	3	136	2	18343819
Pubmed	NOD1 cooperates with HAX-1 to promote cell migration in a RIPK2- and NF-ĸB-independent manner.	RIPK2 HAX1	4.54e-05	3	136	2	37488967
Pubmed	Epithelial-specific ERBB3 deletion results in a genetic background-dependent increase in intestinal and colon polyps that is mediated by EGFR.	ERBB3 APC	4.54e-05	3	136	2	34843459
Pubmed	VCIP135 deubiquitinase and its binding protein, WAC, in p97ATPase-mediated membrane fusion.	WAC VCPIP1	4.54e-05	3	136	2	21811234
Pubmed	Tumor-specific apoptosis caused by deletion of the ERBB3 pseudo-kinase in mouse intestinal epithelium.	ERBB3 APC	4.54e-05	3	136	2	19690388
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	ILDR2 MAP1A PABPC4 APC MAP7 MPRIP PACS1 MAP1S LZTS1 OSBPL10 LIMCH1 HAX1 SSH2 BSN MAPK8IP2 AGAP2 CPSF7	4.57e-05	1431	136	17	37142655
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	TREX1 TBX3 TMEM201 MECOM DIDO1 MAP7 GTF2IRD1 TFAP2C MXD4 WAC CDK13 KDM1B TAPBP HCFC1 CPSF7 VCPIP1	4.86e-05	1294	136	16	30804502
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	TBX3 ERBB3 MYO19 APC SLCO4A1 DIDO1 MAST2 PACS1 CDK13 OSBPL10 HCFC1	5.28e-05	650	136	11	38777146
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	ATMIN SHROOM3 TP53INP1 MYCBP2 CCDC85C CHCHD6 GTF2IRD1 PLEKHH1 PLEKHG4B PACS1 PPARGC1B PTPRJ CDK13 CDYL2 ACSF3 LIMCH1 CAP2	7.44e-05	1489	136	17	28611215
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	ERBB3 SHROOM3 CCDC85C FAM83H MPRIP PTPRJ NFKBIE LIMCH1 HCFC1 VCPIP1	8.07e-05	565	136	10	25468996
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	TMEM201 SYNM APC CCDC85C EIF4ENIF1 GLI3 VCPIP1	8.31e-05	263	136	7	34702444
Pubmed	Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling.	ERBB3 MYCBP2 CHCHD6 GTF2IRD1 DLC1 AJAP1 MN1	8.72e-05	265	136	7	19240061
Pubmed	Gut microbial metabolism drives transformation of MSH2-deficient colon epithelial cells.	RIPK2 APC	9.06e-05	4	136	2	25036629
Pubmed	Mea6 controls VLDL transport through the coordinated regulation of COPII assembly.	MIA2 CTAGE1	9.06e-05	4	136	2	27311593
Pubmed	Multiple quantitative trait loci modify cochlear hair cell degeneration in the Beethoven (Tmc1Bth) mouse model of progressive hearing loss DFNA36.	TMC2 MAP1A	9.06e-05	4	136	2	16648588
Pubmed	Binding of PTEN to specific PDZ domains contributes to PTEN protein stability and phosphorylation by microtubule-associated serine/threonine kinases.	MAST2 MAST3	9.06e-05	4	136	2	15951562
Pubmed	Conditional MN1-TEL knock-in mice develop acute myeloid leukemia in conjunction with overexpression of HOXA9.	HOXA9 MN1	9.06e-05	4	136	2	16105979
Pubmed	Deletion of Mea6 in Cerebellar Granule Cells Impairs Synaptic Development and Motor Performance.	MIA2 CTAGE1	9.06e-05	4	136	2	33718348
Pubmed	Specific expression and regulation of the new melanoma inhibitory activity-related gene MIA2 in hepatocytes.	MIA2 CTAGE1	9.06e-05	4	136	2	12586826
Pubmed	Suppression of colon cancer metastasis by Aes through inhibition of Notch signaling.	APC TLE1	9.06e-05	4	136	2	21251616
Pubmed	Positional cloning of the Chediak-Higashi syndrome gene: genetic mapping of the beige locus on mouse chromosome 13.	GTF2IRD1 GLI3	9.06e-05	4	136	2	8952226
Pubmed	MEA6 Deficiency Impairs Cerebellar Development and Motor Performance by Tethering Protein Trafficking.	MIA2 CTAGE1	9.06e-05	4	136	2	31244610
Pubmed	Reduced cholesterol and triglycerides in mice with a mutation in Mia2, a liver protein that localizes to ER exit sites.	MIA2 CTAGE1	9.06e-05	4	136	2	21807889
Pubmed	PGC-1alpha/beta upregulation is associated with improved oxidative phosphorylation in cells harboring nonsense mtDNA mutations.	PPRC1 PPARGC1B	9.06e-05	4	136	2	17341490
Pubmed	Prognostic significance of combined MN1, ERG, BAALC, and EVI1 (MEBE) expression in patients with myelodysplastic syndromes.	MECOM MN1	9.06e-05	4	136	2	22488406
Pubmed	Mitotic phosphorylation of VCIP135 blocks p97ATPase-mediated Golgi membrane fusion.	WAC VCPIP1	9.06e-05	4	136	2	23500464
Pubmed	EB1-binding-myomegalin protein complex promotes centrosomal microtubules functions.	PABPC4 APC FAM83H TUBGCP6	1.11e-04	63	136	4	29162697
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SYNM GPRIN3 CCDC85A WAC CCDC88C CDK13 CEP135 SSH2 MAST3	1.47e-04	493	136	9	15368895
Pubmed	Large scale localization of protein phosphorylation by use of electron capture dissociation mass spectrometry.	MIA2 CTAGE1	1.51e-04	5	136	2	19131326
Pubmed	TWIST1-WDR5-Hottip Regulates Hoxa9 Chromatin to Facilitate Prostate Cancer Metastasis.	APC HOXA9	1.51e-04	5	136	2	28484075
Pubmed	cTAGE: a cutaneous T cell lymphoma associated antigen family with tumor-specific splicing.	MIA2 CTAGE1	1.51e-04	5	136	2	12839582
Pubmed	Intracellular role for sphingosine kinase 1 in intestinal adenoma cell proliferation.	APC S1PR2	1.51e-04	5	136	2	16980623
Pubmed	Specific phosphopeptide enrichment with immobilized titanium ion affinity chromatography adsorbent for phosphoproteome analysis.	MIA2 CTAGE1	1.51e-04	5	136	2	18630941
Pubmed	Characterization and expression pattern of the novel MIA homolog TANGO.	MIA2 CTAGE1	1.51e-04	5	136	2	15183315
Pubmed	Physical mapping of the beige critical region on mouse chromosome 13.	GTF2IRD1 GLI3	1.51e-04	5	136	2	8854868
Pubmed	Mea6/cTAGE5 cooperates with TRAPPC12 to regulate PTN secretion and white matter development.	MIA2 CTAGE1	1.51e-04	5	136	2	38439956
Pubmed	A tissue-specific atlas of mouse protein phosphorylation and expression.	MIA2 CTAGE1	1.51e-04	5	136	2	21183079
Pubmed	BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors.	NELFE DIDO1 WAC HCFC1 CPSF7	1.89e-04	134	136	5	25452129
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ATMIN PPRC1 CAMTA2 PLEKHH1 DENND4B MARK4 LIMCH1 VCPIP1	2.10e-04	407	136	8	12693553
Pubmed	Genetic and molecular control of folate-homocysteine metabolism in mutant mice.	APC GLI3	2.25e-04	6	136	2	12016514
Pubmed	Cardiac malformations, adrenal agenesis, neural crest defects and exencephaly in mice lacking Cited2, a new Tfap2 co-activator.	ERBB3 TFAP2C	2.25e-04	6	136	2	11694877
Pubmed	Structural and histone binding ability characterizations of human PWWP domains.	BRPF1 PWWP3A	2.25e-04	6	136	2	21720545
Pubmed	Peroxisome proliferator-activated receptor gamma coactivator 1beta (PGC-1beta ), a novel PGC-1-related transcription coactivator associated with host cell factor.	PPARGC1B HCFC1	2.25e-04	6	136	2	11733490
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SHROOM3 DIDO1 CRTC1 TIAM2 TUBGCP6 CELSR3 PLCH2 LRP4 BSN	2.47e-04	529	136	9	14621295
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	MYCBP2 APC CCDC85C MECOM CRTC1 EIF4ENIF1 TLE1 VCPIP1	2.51e-04	418	136	8	34709266
Pubmed	Genome-wide association study identifies eight loci associated with blood pressure.	CNNM2 MECOM TMEM26	2.67e-04	32	136	3	19430483
Pubmed	BioID-based Identification of Skp Cullin F-box (SCF)β-TrCP1/2 E3 Ligase Substrates.	APC MAST2 MAP1S HCFC1 MAST3 VCPIP1	2.74e-04	226	136	6	25900982
Pubmed	Lynch Syndrome	APC DLC1 PTPRJ	2.93e-04	33	136	3	20301390
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	SHROOM3 MAP1A PLEKHG4B MIA2 EIF4ENIF1 MAP1S PLCH2 BSN	3.04e-04	430	136	8	35044719
Pubmed	Comprehensive identification of phosphorylation sites in postsynaptic density preparations.	MAP1A MPRIP BSN MAST3 AGAP2 VCPIP1	3.08e-04	231	136	6	16452087
Pubmed	DIPA-family coiled-coils bind conserved isoform-specific head domain of p120-catenin family: potential roles in hydrocephalus and heterotopia.	CCDC85C CCDC85A	3.15e-04	7	136	2	25009281
Pubmed	cTAGE5 deletion in pancreatic β cells impairs proinsulin trafficking and insulin biogenesis in mice.	MIA2 CTAGE1	3.15e-04	7	136	2	29133483
Pubmed	Tau knockout exacerbates degeneration of parvalbumin-positive neurons in substantia nigra pars reticulata in Parkinson's disease-related α-synuclein A53T mice.	MAP1A PITX3	3.15e-04	7	136	2	33000527
Pubmed	Rare mutations in N-methyl-D-aspartate glutamate receptors in autism spectrum disorders and schizophrenia.	GPRIN3 GRIN2C	3.15e-04	7	136	2	22833210
Pubmed	Lrp4 and Wise interplay controls the formation and patterning of mammary and other skin appendage placodes by modulating Wnt signaling.	ERBB3 APC LRP4	3.20e-04	34	136	3	23293290
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	VWA5B2 PDZD7 PLEKHH1 GLI3 BSN MAPK8IP2	3.23e-04	233	136	6	37704626
Pubmed	Mouse chromosomal locations of nine genes encoding homologs of human paraneoplastic neurologic disorder antigens.	ERBB3 GRIN2C IL4R	3.80e-04	36	136	3	9344654
Pubmed	Ca2+ entry through mechanotransduction channels localizes BAIAP2L2 to stereocilia tips.	TMC2 BAIAP2L2	4.19e-04	8	136	2	35044843
Pubmed	A novel mechanism for the transcriptional regulation of Wnt signaling in development.	APC TLE1	4.19e-04	8	136	2	21856776
Pubmed	Molecular genetics of the human MHC complement gene cluster.	NELFE CYP21A2	4.19e-04	8	136	2	10072631
Pubmed	Enhancer redundancy provides phenotypic robustness in mammalian development.	TBX3 GLI3	4.19e-04	8	136	2	29420474
Pubmed	Delayed maturation and migration of excitatory neurons in the juvenile mouse paralaminar amygdala.	KCNH7 APC MAST2	4.46e-04	38	136	3	38086370
Pubmed	The chromatin regulator Brpf1 regulates embryo development and cell proliferation.	MECOM HOXA9 BRPF1	5.20e-04	40	136	3	25773539
Pubmed	Identification of high-molecular-weight proteins with multiple EGF-like motifs by motif-trap screening.	CELSR3 LRP4	5.37e-04	9	136	2	9693030
Pubmed	Human peroxisome proliferator activated receptor gamma coactivator 1 (PPARGC1) gene: cDNA sequence, genomic organization, chromosomal localization, and tissue expression.	SHROOM3 PPARGC1B	5.37e-04	9	136	2	10585775
Pubmed	Misexpression of MIA disrupts lung morphogenesis and causes neonatal death.	MIA2 CTAGE1	5.37e-04	9	136	2	18342301
Pubmed	Tau haploinsufficiency causes prenatal loss of dopaminergic neurons in the ventral tegmental area and reduction of transcription factor orthodenticle homeobox 2 expression.	MAP1A PITX3	5.37e-04	9	136	2	28424350
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	APC GPRIN3 CHCHD6 TUBGCP6 CDAN1 KANK4 LIMCH1 MAST3	5.86e-04	475	136	8	31040226
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	PABPC4 APC CCDC85C BUD13 CHCHD6 FAM83H MPRIP TUBGCP6 PACS1 MAP1S PARD6A CEP135 HCFC1	6.23e-04	1155	136	13	20360068
Pubmed	An inter-species protein-protein interaction network across vast evolutionary distance.	CAMTA2 EFCAB14 WAC CATSPER1 EIF4ENIF1 CBY2 CAP2 CPSF7	6.53e-04	483	136	8	27107014
Pubmed	The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1.	KDM1B HCFC1	6.69e-04	10	136	2	19815555
Pubmed	Confirmation of the genetic association of CTLA4 and PTPN22 with ANCA-associated vasculitis.	ERBB3 CYP27B1	6.69e-04	10	136	2	19951419
Pubmed	Genome-wide association studies of serum magnesium, potassium, and sodium concentrations identify six Loci influencing serum magnesium levels.	SHROOM3 MECOM	6.69e-04	10	136	2	20700443
Pubmed	Follicular dendritic cells restrict interleukin-4 availability in germinal centers and foster memory B cell generation.	S1PR2 IL4R	6.69e-04	10	136	2	34555336
Pubmed	Pitx1 determines the morphology of muscle, tendon, and bones of the hindlimb.	TBX3 GLI3	6.69e-04	10	136	2	16989801
Pubmed	An atlas of combinatorial transcriptional regulation in mouse and man.	NELFE APC DBP MXD4 HOXA9 PPARGC1B TLE1 GLI3 BRPF1 PITX3 HCFC1	6.89e-04	877	136	11	20211142
Pubmed	Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer.	SHROOM3 MYCBP2 APC MPRIP	7.07e-04	102	136	4	15778465
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	NELFE ATMIN SLCO4A1 MECOM TFAP2C WAC CDK13 TLE1 GLI3 CEP135 NPAP1 SSH2 CPEB1 CPSF7	7.24e-04	1327	136	14	32694731
Pubmed	Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies.	CRTC1 CCDC85A ECE2	7.85e-04	46	136	3	21102462
Pubmed	Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	PPRC1 PCDHGA12 ECE2 MAST3	7.88e-04	105	136	4	9628581
Interaction	YWHAH interactions	NELFE SHROOM3 MYCBP2 RIPK2 PLEKHA4 APC CCDC85C CRTC1 MAP7 MAST2 FAM83H MPRIP CCDC88C PACS1 PARD6A MARK4 CEP135 MAP3K9 OSBPL10 LIMCH1 SSH2 MAST3 CPEB1 VCPIP1	2.88e-07	1102	135	24	int:YWHAH
Interaction	SYTL5 interactions	CCDC85C CCDC85A WAC LIMCH1	5.48e-06	18	135	4	int:SYTL5
Interaction	FBXW11 interactions	PABPC4 PLEKHA4 APC GTF2IRD1 MAST2 FAM83H TUBGCP6 EIF4ENIF1 MAP1S GLI3 HCFC1 MAPK8IP2 MAST3	1.81e-05	473	135	13	int:FBXW11
Interaction	YWHAG interactions	NELFE BNIP5 SHROOM3 MYCBP2 PABPC4 RIPK2 PLEKHA4 APC CCDC85C CRTC1 MAP7 MAST2 FAM83H MPRIP CCDC88C PACS1 DLC1 MARK4 MAP3K9 OSBPL10 SSH2 MAST3	2.80e-05	1248	135	22	int:YWHAG
Interaction	YWHAE interactions	NELFE BNIP5 SHROOM3 MYCBP2 PABPC4 RIPK2 PLEKHA4 APC CCDC85C CRTC1 MAP7 MAST2 FAM83H MPRIP CCDC88C PACS1 CDK13 MARK4 MAP3K9 SSH2 CAP2 MAST3	3.08e-05	1256	135	22	int:YWHAE
Cytoband	10q24.32	CNNM2 PPRC1 PITX3	4.92e-05	24	136	3	10q24.32
Cytoband	19p13.11	CRTC1 MAP1S GTPBP3 MAST3	6.84e-05	73	136	4	19p13.11
Cytoband	16q23.2	ATMIN CDYL2	4.71e-04	11	136	2	16q23.2
GeneFamily	PDZ domain containing	SHROOM3 PDZD7 MAST2 TIAM2 PARD6A FRMPD3 MAST3	1.08e-05	152	90	7	1220
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	PLEKHA4 TIAM2 MPRIP PLEKHH1 PLEKHG4B OSBPL10 AGAP2	7.56e-05	206	90	7	682
Coexpression	MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3	ERBB3 SYNM CCDC85A KIAA1549L CELSR3 KANK4 MAP3K9 MAPK8IP2	8.43e-07	143	136	8	M1935
Coexpression	MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3	ERBB3 SYNM CCDC85A KIAA1549L CELSR3 KANK4 MAP3K9 MAPK8IP2	8.43e-07	143	136	8	MM819
Coexpression	BHAT_ESR1_TARGETS_VIA_AKT1_DN	SHROOM3 DBP GTF2IRD1 TLE1 CDYL2 BCAR3	4.43e-06	82	136	6	M2235
Coexpression	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN	SHROOM3 DBP GTF2IRD1 TLE1 OSBPL10 CDYL2	6.68e-06	88	136	6	M2232
Coexpression	IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR	ILDR2 BNIP5 TMEM201 CRTC1 CHCHD6 MXD4 MPRIP HOXA9 MAP1S ACSF3 BSN MN1 CPEB1	9.65e-06	574	136	13	M8215
Coexpression	MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3	ERBB3 SYNM CCDC85A KIAA1549L CELSR3 MAP3K9 MAPK8IP2 CPEB1	1.45e-05	210	136	8	M2010
Coexpression	IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR	ILDR2 BNIP5 TMEM201 CRTC1 CHCHD6 MXD4 MPRIP HOXA9 MAP1S ACSF3 BSN MN1 CPEB1	1.54e-05	600	136	13	MM1025
Coexpression	MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3	ERBB3 SYNM CCDC85A KIAA1549L CELSR3 MAP3K9 MAPK8IP2 CPEB1	1.84e-05	217	136	8	MM861
Coexpression	HOLLERN_EMT_BREAST_TUMOR_DN	ERBB3 SHROOM3 MAP7 TFAP2C FAM83H PLEKHH1	4.51e-05	123	136	6	M624
Coexpression	HOLLERN_EMT_BREAST_TUMOR_DN	ERBB3 SHROOM3 MAP7 TFAP2C FAM83H PLEKHH1	7.58e-05	135	136	6	MM965
CoexpressionAtlas	FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000	ZMYND15 COL6A3 TBX3 DRP2 TP53INP1 SYNM SLCO4A1 TIAM2 WAC FNDC1 KIAA1549L RTL1 CBY2 GLI3 PLCH2 CEP135 KANK4 LRP4 LIMCH1 TTLL10	3.03e-06	979	133	20	Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000	ILDR2 COL6A3 TBX3 ERBB3 SHROOM3 JPH4 CCDC85C SLCO4A1 MECOM MAP7 PLEKHH1 CCDC88C FNDC1 KIAA1549L PTPRJ PLCH2 TTLL10 TMEM26 MAPK8IP2	1.04e-05	973	133	19	Facebase_RNAseq_e9.5_Olfactory Placode_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000	ILDR2 COL6A3 TBX3 MAP1A SYNM MECOM MAP7 CCDC88C AJAP1 KIAA1549L PTPRJ RTL1 GLI3 DENND4B CEP135 LRP4 KDM1B TMEM26 MAPK8IP2	1.20e-05	983	133	19	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000	ZMYND15 COL6A3 TBX3 JPH4 TP53INP1 MAP1A MECOM IRAK1BP1 MAP7 ZFAND4 FNDC1 CATSPER1 KIAA1549L PTPRJ GLI3 DENND4B KANK4 TMEM26	3.72e-05	973	133	18	Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000	ILDR2 COL6A3 TBX3 ERBB3 SHROOM3 JPH4 SLCO4A1 MECOM MAP7 PLEKHH1 CCDC88C FNDC1 KIAA1549L PTPRJ PLCH2 TTLL10 TMEM26 MAPK8IP2	4.30e-05	984	133	18	Facebase_RNAseq_e10.5_Olfactory Pit_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000	ZMYND15 TREX1 TBX3 APC SLCO4A1 MECOM IRAK1BP1 EFCAB14 MAP7 GTF2IRD1 ZFAND4 WAC CATSPER1 GLI3 PLCH2 KANK4 LIMCH1 TTLL10	4.59e-05	989	133	18	Facebase_RNAseq_e10.5_Maxillary Arch_1000
CoexpressionAtlas	FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_500	TREX1 COL6A3 TBX3 JPH4 SLCO4A1 MECOM RGS10 CCDC85A FNDC1 KIAA1549L PTPRJ TMEM26	5.89e-05	488	133	12	Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_1000	TBX3 ERBB3 EFCAB14 DBP PLCH2 TTLL10	6.12e-05	108	133	6	gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500	ZMYND15 TBX3 SLCO4A1 MECOM IRAK1BP1 MAP7 ZFAND4 CATSPER1 GLI3 PLCH2 KANK4 TTLL10	6.36e-05	492	133	12	Facebase_RNAseq_e10.5_Maxillary Arch_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4	COL6A3 TBX3 DRP2 SLCO4A1 WAC CBY2 GLI3 CEP135 LIMCH1	1.11e-04	298	133	9	Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4
CoexpressionAtlas	FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000	ILDR2 COL6A3 TBX3 SHROOM3 JPH4 MAP1A SLCO4A1 MECOM MAP7 CCDC88C FNDC1 AJAP1 KIAA1549L PTPRJ GLI3 TMEM26 MAPK8IP2	1.29e-04	976	133	17	Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000
CoexpressionAtlas	DevelopingKidney_e11.5_ureteric bud_emap-3844_k-means-cluster#5_top-relative-expression-ranked_1000	ERBB3 MECOM TFAP2C CCDC88C KIAA1549L MAP3K9 SSH2 BCAR3 CPEB1	1.36e-04	306	133	9	gudmap_developingKidney_e11.5_ureteric bud_1000_k5
CoexpressionAtlas	FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#4	TBX3 MECOM PTPRJ KANK4 LIMCH1	1.66e-04	82	133	5	Facebase_RNAseq_e9.5_Mandibular Arch_500_K4
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_k-means-cluster#1_top-relative-expression-ranked_1000	ERBB3 MAP7 TFAP2C FAM83H PLEKHH1 PLCH2 MAP3K9	1.86e-04	188	133	7	gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_1000_k1
CoexpressionAtlas	FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#1	TBX3 MECOM S1PR2 PTPRJ KANK4 LIMCH1	2.09e-04	135	133	6	Facebase_RNAseq_e9.5_Mandibular Arch_1000_K1
CoexpressionAtlas	facebase_RNAseq_e9.5_OlfPlac_2500_K2	ERBB3 MAP7 TFAP2C FAM83H PLEKHH1 PLCH2 MAP3K9 BCAR3 TTLL10	2.28e-04	328	133	9	facebase_RNAseq_e9.5_OlfPlac_2500_K2
CoexpressionAtlas	FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_500	ZMYND15 TP53INP1 MAP1A IRAK1BP1 MAP7 ZFAND4 CATSPER1 GLI3 DENND4B KANK4 TMEM26	2.66e-04	490	133	11	Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500	ILDR2 MAP1A MECOM MAP7 CCDC88C AJAP1 KIAA1549L GLI3 CEP135 KDM1B MAPK8IP2	2.80e-04	493	133	11	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500	ILDR2 ERBB3 SHROOM3 MECOM MAP7 PLEKHH1 CCDC88C KIAA1549L PLCH2 TTLL10 MAPK8IP2	2.90e-04	495	133	11	Facebase_RNAseq_e10.5_Olfactory Pit_500
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_500	ILDR2 TREX1 SHROOM3 MAP7 PLEKHH1 CCDC88C AJAP1 KIAA1549L RTL1 TTLL10 MAPK8IP2	2.90e-04	495	133	11	Facebase_RNAseq_e8.5_Floor Plate_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500	ILDR2 MAP1A SLCO4A1 MAP7 CCDC88C AJAP1 KIAA1549L GLI3 PLCH2 CEP135 TTLL10	3.05e-04	498	133	11	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500
CoexpressionAtlas	FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000	COL6A3 TBX3 JPH4 DRP2 CCDC85C SLCO4A1 MECOM CCDC85A CCDC88C FNDC1 KIAA1549L PTPRJ RTL1 KANK4 LIMCH1 TMEM26	3.66e-04	967	133	16	Facebase_RNAseq_e9.5_Maxillary Arch_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500_k-means-cluster#4	ILDR2 PLEKHH1 CCDC88C KIAA1549L PLCH2	3.81e-04	98	133	5	Facebase_RNAseq_e10.5_Olfactory Pit_500_K4
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_k-means-cluster#3_top-relative-expression-ranked_500	ERBB3 TFAP2C FAM83H PLEKHH1 PLCH2	4.58e-04	102	133	5	gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_500_k3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000	ILDR2 MAP1A SLCO4A1 MECOM MAP7 GTF2IRD1 CCDC88C CATSPER1 AJAP1 KIAA1549L CBY2 GLI3 PLCH2 CEP135 TTLL10 MAPK8IP2	4.68e-04	989	133	16	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000
CoexpressionAtlas	gudmap_RNAseq_e11.5_Ureteric_stalks_2500_K2	TBX3 ERBB3 MAP7 TFAP2C FAM83H HOXA9 PLCH2 KANK4 BCAR3 TTLL10	4.69e-04	441	133	10	gudmap_RNAseq_e11.5_Ureteric_stalks_2500_K2
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_k-means-cluster#3_top-relative-expression-ranked_200	ERBB3 TFAP2C FAM83H PLCH2	5.13e-04	59	133	4	gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_200_k3
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000	TBX3 ERBB3 DRP2 MYCBP2 APC EFCAB14 DBP TFAP2C GLI3 PLCH2 KANK4 TTLL10 MN1 CAP2	5.40e-04	806	133	14	gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000
CoexpressionAtlas	kidney_e10.5_UretericTip_HoxB7_k-means-cluster#3_top-relative-expression-ranked_100	TBX3 MECOM	5.75e-04	6	133	2	gudmap_kidney_e10.5_UretericTip_HoxB7_k3_100
CoexpressionAtlas	cerebral cortex	ILDR2 JPH4 KCNH7 DRP2 MAP1A APC GRIN2C CCDC85A TIAM2 GJD4 PLEKHH1 AJAP1 KIAA1549L CELSR3 LRP4 FRMPD3 BSN MAPK8IP2 CAP2 AGAP2	5.77e-04	1428	133	20	cerebral cortex
ToppCell	10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	PLEKHA4 FNDC1 KIAA1549L GLI3 PITX3 KANK4 LRP4 LIMCH1 CAP2	9.34e-09	195	136	9	ec12cfb2fce44cc2de4e198ef5af075e626f0329
ToppCell	10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ERBB3 MAP1A MAP7 PLEKHH1 DLC1 CERCAM LIMCH1 CPEB1	1.85e-07	199	136	8	5d2e85e40b6b52b1809e680b952913d77215b3d0
ToppCell	10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ERBB3 MAP1A MAP7 PLEKHH1 DLC1 CERCAM LIMCH1 CPEB1	1.85e-07	199	136	8	9dd4b17fb8c70ab9e126b23b72600463f3db832d
ToppCell	10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ERBB3 MAP1A MAP7 PLEKHH1 DLC1 CERCAM LIMCH1 CPEB1	1.85e-07	199	136	8	6fb5f931e6217142de38c1fffc011e63bda4772b
ToppCell	10x_5'_v1-Non-neoplastic-Glial-Neuronal\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ERBB3 MAP1A MAP7 PLEKHH1 DLC1 CERCAM LIMCH1 CPEB1	1.85e-07	199	136	8	1bb5797e8e0552bf9b44bf4c958d1aa6dbe6c756
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MECOM PLEKHG4B CCDC88C NPAP1 LIMCH1 SSH2 BCAR3	1.66e-06	185	136	7	d602a9b35e86e6f2a14a58e40fc4fb97f5fa3b08
ToppCell	(04)_Pre-ciliated\|World / shred by cell type and Timepoint	NELFE ILDR2 MAP1A IRAK1BP1 MAST2 ZFAND4 CEP135	2.05e-06	191	136	7	37cf121e6e80760c8519075b7845b9029958a988
ToppCell	COVID-19-lung-Capillary_Aerocytes\|lung / Disease (COVID-19 only), tissue and cell type	ILDR2 TBX3 SLCO4A1 CCDC85A AJAP1 TMEM26 IL4R	2.43e-06	196	136	7	4ac4073380d939a73cec7413e9f3f5ef616d2924
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ERBB3 MAP1A MAP7 PLEKHH1 CERCAM LIMCH1 CPEB1	2.78e-06	200	136	7	acdef0b9096c774040948fc75621ff2b08ea2ee8
ToppCell	droplet-Lung-nan-3m-Myeloid-intermediate_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BNIP5 TREX1 ERBB3 GRIN2C TIAM2 PTPRJ	5.19e-06	143	136	6	4d11d53330a9197275a8851e1bbf55a113715a09
ToppCell	droplet-Lung-nan-3m-Myeloid-Intermediate_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BNIP5 TREX1 ERBB3 GRIN2C TIAM2 PTPRJ	5.19e-06	143	136	6	8b9f4d87d5faac7752c83e1992491fc5550600f8
ToppCell	droplet-Marrow-BM-30m-Lymphocytic-plasma_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZMYND15 VWA5B2 RGS10 FNDC1 PTPRJ TMEM26	1.14e-05	164	136	6	758e85e2f5e7236b345e16c78344d5e0bf17d8dc
ToppCell	356C-Myeloid-Dendritic-cDC1\|356C / Donor, Lineage, Cell class and subclass (all cells)	ZMYND15 RGS10 PLEKHH1 PLEKHG4B HOXA9 CPEB1	1.22e-05	166	136	6	0590e404f45afce90e20f93f90a3def83949c66b
ToppCell	Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	RTL1 PITX3 KANK4 CERCAM BSN TMEM26	1.22e-05	166	136	6	6a6ed5c7a43fee9a8a9be42dfa99303815b8e8ef
ToppCell	droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL6A3 MECOM KIAA1549L GLI3 LRP4 LIMCH1	1.30e-05	168	136	6	d2b91f2adc95dcfa623f8d7ca2df1c6f884da988
ToppCell	droplet-Lung-LUNG-1m-Myeloid-Ccr7+_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZMYND15 TRIM7 DENND4B NFKBIE CERCAM KDM1B	1.59e-05	174	136	6	7be0c6248e77f2d0260b852b01e17892f7828f1b
ToppCell	facs-Lung-EPCAM-3m-Mesenchymal-adventitial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 MAP1A S1PR2 KIAA1549L CERCAM MN1	1.81e-05	178	136	6	27497dbfcf9bb4dd0bf7caa0bd78c7e85f5c18ee
ToppCell	facs-Lung-EPCAM-3m-Mesenchymal-Adventitial_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 MAP1A S1PR2 KIAA1549L CERCAM MN1	1.81e-05	178	136	6	d348a9550db940d204706529759dc51e30506b5f
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CNNM2 KCNH7 MECOM GTF2IRD1 LIMCH1 BCAR3	1.87e-05	179	136	6	666072c0e8448dbaec1683d18368ec2502453f90
ToppCell	LA-07._Pericyte\|World / Chamber and Cluster_Paper	GPRIN3 DLC1 LZTS1 TLE1 OSBPL10 AGAP2	2.12e-05	183	136	6	e3835db4795362b0442d5893baf2a78efcc20428
ToppCell	COVID-19-Heart-Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	GPRIN3 MPRIP DLC1 LZTS1 TLE1 AGAP2	2.18e-05	184	136	6	21790cdfa3b4036ad413fd44b94e31563116f25f
ToppCell	COVID-19-Epithelial_cells-Airway_club\|COVID-19 / group, cell type (main and fine annotations)	ERBB3 SHROOM3 MECOM MAP7 PLEKHG4B LIMCH1	2.25e-05	185	136	6	cfe6fd73d817e173fe803bc1683c291d9bcb8608
ToppCell	ILEUM-inflamed-(8)_Fibroblast-(8)_Smooth_muscle_cells\|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	TBX3 SYNM RGS10 LRP4 LIMCH1 MAPK8IP2	2.32e-05	186	136	6	cacc2f0b2ed46516173b61ba1c5c226a2db7cddc
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MECOM CCDC88C NPAP1 LIMCH1 SSH2 BCAR3	2.39e-05	187	136	6	e3095455d2f255854f339f6b05fa87852af0700f
ToppCell	COVID-19-kidney-DCT\|kidney / Disease (COVID-19 only), tissue and cell type	SHROOM3 CNNM2 MECOM GPRIN3 GTF2IRD1 LIMCH1	2.46e-05	188	136	6	df1fd0819d301679f3c9ea404e942e39095912eb
ToppCell	droplet-Kidney-nan-18m-Epithelial-kidney_mesangial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBX3 MAP1A TRARG1 SYNM DLC1 CAP2	2.46e-05	188	136	6	d1a4cd4db95d8d32b79156290f7867f32824cc87
ToppCell	COVID-19-Heart-EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	MECOM CCDC85A DLC1 LZTS1 TLE1 AGAP2	2.61e-05	190	136	6	a21653bfb7bafbc273f94fa7c13bfb48cf8fd562
ToppCell	COPD-Epithelial-Club\|COPD / Disease state, Lineage and Cell class	ERBB3 SHROOM3 MECOM MAP7 TFAP2C LIMCH1	2.69e-05	191	136	6	c909cf5fa0e6519aa93a47d2c3fcd2ae2163cd8d
ToppCell	Control-Epithelial-Club\|Control / Disease state, Lineage and Cell class	ERBB3 SHROOM3 MECOM MAP7 TFAP2C LIMCH1	2.77e-05	192	136	6	d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ERBB3 MAP7 PLEKHH1 CERCAM LIMCH1 CPEB1	2.77e-05	192	136	6	8dc3016601148243196e925641c9507e9d58c9e0
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-10\|TCGA-Colorectal / Sample_Type by Project: Shred V9	MAP1A FNDC1 PCDHGA12 LZTS1 GLI3 MN1	2.85e-05	193	136	6	194e7fa00a50cc4e026987b715323d125d79594e
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SHROOM3 MECOM MAP7 GTF2IRD1 SSH2 BCAR3	2.94e-05	194	136	6	46070fbb0ee0eb9e1801c43b73a15707471056dc
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SHROOM3 MECOM MAP7 GTF2IRD1 SSH2 BCAR3	2.94e-05	194	136	6	abacb6a8d7a9003f2f6c2be0305507f1c1c50347
ToppCell	5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A3 TBX3 RGS10 AJAP1 LRP4 LIMCH1	3.11e-05	196	136	6	1f47916c2663bd88c1e7c19c6a7688f4c7173ad2
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ILDR2 JPH4 KCNH7 PLEKHG4B CELSR3 BSN	3.11e-05	196	136	6	4bdc304c0c9d8bebe1a6a8a27e44acd1e8113725
ToppCell	COVID-19-lung-Capillary_Aerocytes\|COVID-19 / Disease (COVID-19 only), tissue and cell type	TBX3 SLCO4A1 CCDC85A AJAP1 TMEM26 IL4R	3.11e-05	196	136	6	49cc0a2b9739abad61dff7292ea0b14d28ff35c4
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A3 TBX3 RGS10 HOXA9 LRP4 LIMCH1	3.20e-05	197	136	6	ea746772adb9df4ddb0508d4ef35f2027bf09c35
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A3 JPH4 DLC1 CERCAM TMEM26 MN1	3.29e-05	198	136	6	9541d68a1a6247dbd7161a62644eea6527c2c8ff
ToppCell	3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A3 TBX3 RGS10 AJAP1 LRP4 LIMCH1	3.29e-05	198	136	6	447d7182edb2cd8a72ebd3c0d16bc6e4ddcaaa5c
ToppCell	Fibroblasts-HLA-DRA_high_Fibroblasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	COL6A3 PLEKHA4 FNDC1 DLC1 GLI3 CERCAM	3.29e-05	198	136	6	e8c0fbf306fae13e97caa294d7c99a564bd97130
ToppCell	10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	COL6A3 FNDC1 GLI3 LRP4 CERCAM LIMCH1	3.29e-05	198	136	6	bc9c9f2c87282b5ef8514773e065d2a6b5dde338
ToppCell	distal-1-Epithelial-Club\|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ERBB3 SHROOM3 MECOM TFAP2C LIMCH1 MUC20	3.39e-05	199	136	6	8f0a72a95d0310ef2324c6975495c294b5a47cc8
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	COL6A3 MYCBP2 PLEKHA4 NFKBIE LIMCH1 IL4R	3.39e-05	199	136	6	fde2b65afde69f402f1b7b056eaa266e9fd5b227
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	MECOM PACS1 PTPRJ OSBPL10 LIMCH1 SSH2	3.39e-05	199	136	6	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors\|1_mon / Sample Type, Dataset, Time_group, and Cell type.	CCDC85C RGS10 WAC GLI3 MN1 HCFC1	3.39e-05	199	136	6	358c4b3037f59378db8916a2fbe9ed4830cf1449
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ERBB3 MAP7 PLEKHH1 PLCH2 CERCAM LIMCH1	3.48e-05	200	136	6	3ce8a2db8c25e1169a0a544f644a63104749c5ee
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ERBB3 MAP7 PLEKHH1 CERCAM LIMCH1 CPEB1	3.48e-05	200	136	6	091a18d6efed81cab99955c3047f172170f70476
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ERBB3 MAP7 PLEKHH1 CERCAM LIMCH1 CPEB1	3.48e-05	200	136	6	3b8513defe25262ab4b492345b2628570eaefd17
ToppCell	E17.5-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	PLEKHA4 S1PR2 BRPF1 LRP4 KDM1B	9.76e-05	150	136	5	201d5b68e71c6c003285428be96c488e6d526edf
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SHROOM3 KCNH7 MECOM GTF2IRD1 LIMCH1	1.07e-04	153	136	5	79c4f4ccdc8249c8461075c73491bc3b2d13344a
ToppCell	PND28-Immune-Immune_Myeloid-Granulocytic-Basophil\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PLEKHA4 CAMTA2 KIAA1549L CDYL2 SSH2	1.21e-04	157	136	5	8c42af7aa1f1b6f4fe2f8d00a8b4a800f121e804
ToppCell	PND28-Immune-Immune_Myeloid-Granulocytic\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PLEKHA4 CAMTA2 KIAA1549L CDYL2 SSH2	1.21e-04	157	136	5	ee1be3c756b72fceac6b4ccb416dd4bd031a2193
ToppCell	PND28-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PLEKHA4 CAMTA2 KIAA1549L CDYL2 SSH2	1.21e-04	157	136	5	008f938a338f43c3251dcac574f1b4f689926c71
ToppCell	facs-Marrow-B-cells-24m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZMYND15 TREX1 CYP27B1 RGS10 KANK4	1.21e-04	157	136	5	0966e347f8d32b13f8a3b3afba3f64637c69cdf9
ToppCell	facs-Marrow-B-cells-24m-Myeloid-monocyte_+_promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZMYND15 TREX1 CYP27B1 RGS10 KANK4	1.21e-04	157	136	5	6ebfedd91d62c6d4aa8f046657a899a279f82ba2
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SHROOM3 MECOM GPRIN3 GTF2IRD1 LIMCH1	1.28e-04	159	136	5	50d951cf27a571c0c5002003c16fbc370fa17eb1
ToppCell	TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular-6\|TCGA-Stomach / Sample_Type by Project: Shred V9	ZMYND15 SHROOM3 PPRC1 CCDC88C HCFC1	1.28e-04	159	136	5	655c0749c238bd68cb797adb83e25a23b8a3cc9d
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW13-Mesenchymal\|GW13 / Sample Type, Dataset, Time_group, and Cell type.	RIPK2 MAST2 RGS10 MIA2	1.34e-04	85	136	4	3f33e897eb030043905a6a1a83377cd601652958
ToppCell	Mild-MAIT\|Mild / Disease group and Cell class	TRIM7 LZTS1 TLE1 CPEB1 MUC20	1.36e-04	161	136	5	0c1a04485708d5302600cdc2d7dac1cb76b4033a
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	GPRIN3 TIAM2 KIAA1549L LZTS1 CAP2	1.36e-04	161	136	5	ba7ce599b173cf81c8323e7c96dc3d57379f1ed6
ToppCell	normal_Lung-Fibroblasts-Myofibroblasts\|Fibroblasts / Location, Cell class and cell subclass	COL6A3 PLEKHG4B FNDC1 BSN ECE2	1.48e-04	164	136	5	9b4a6007abae992db871d9f6f731d5af724de30d
ToppCell	Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D231\|Adult / Lineage, Cell type, age group and donor	TBX3 SYNM SLCO4A1 AJAP1 CELSR3	1.61e-04	167	136	5	5af9127bae05768a5164d5708a4ad37edca99324
ToppCell	3'_v3-Lung-Lymphocytic_Invariant-Inducer-like-ILC3\|Lung / Manually curated celltypes from each tissue	ILDR2 MAP7 HOXA9 TLE1 TTLL10	1.61e-04	167	136	5	0614d077b47a87f726068615548d0b0a216627be
ToppCell	Control\|World / group, cell type (main and fine annotations)	SHROOM3 MECOM MAP7 DLC1 LIMCH1	1.66e-04	168	136	5	a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6
ToppCell	Control-Epithelial_cells-ECM-high_epithelial\|Control / group, cell type (main and fine annotations)	SHROOM3 MECOM CCDC85A DLC1 LIMCH1	1.75e-04	170	136	5	e2023d66e70983c87dacbd6181d3426488d1fc57
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SHROOM3 MAP1S RTL1 CERCAM MAST3	1.75e-04	170	136	5	b1a16600754e0c12f7d39c9221f1b03135833f16
ToppCell	droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination__)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZMYND15 BNIP5 TP53INP1 MYO19 WAC	1.80e-04	171	136	5	d1e87478d8c0329e662849823f5c7604f20e1b1a
ToppCell	mild_COVID-19_(asymptomatic)-RBC\|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)	IRAK1BP1 MPRIP PARD6A PWWP3A GTPBP3	1.80e-04	171	136	5	78491478ba65bad45238fe114f5251b2adea323d
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_D\|367C / Donor, Lineage, Cell class and subclass (all cells)	HOXA9 CCDC88C MIA2 PLCH2 AGAP2	1.85e-04	172	136	5	6379ae0aca9007c3a8a87e3330908fc90961ad3f
ToppCell	3'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TP53INP1 S1PR2 TIAM2 CATSPER1 PWWP3A	1.85e-04	172	136	5	13d7117f92a92d77d6b4335ed800c585dc8b4511
ToppCell	3'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TP53INP1 S1PR2 TIAM2 CATSPER1 PWWP3A	1.85e-04	172	136	5	3d83b2f03ad3af4dae3fe6cc0a0ef356872ca94f
ToppCell	3'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TP53INP1 S1PR2 TIAM2 CATSPER1 PWWP3A	1.85e-04	172	136	5	a3d431aed12c1192e8dca1dc85b8340fb7354f8d
ToppCell	3'-Airway_Nasal-Immune_Myeloid_mast\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TP53INP1 S1PR2 TIAM2 CATSPER1 PWWP3A	1.85e-04	172	136	5	028a5441242b2cc760cafc1822120180619c63ae
ToppCell	3'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TP53INP1 S1PR2 TIAM2 CATSPER1 PWWP3A	1.85e-04	172	136	5	9fc70b1a143a8ec910336c23b761d908bb6aecb2
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	HOXA9 CATSPER1 TLE1 PLCH2 BAIAP2L2	1.85e-04	172	136	5	e3a8891694343b6b01e80a200ae338d24797e417
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SHROOM3 CNNM2 KCNH7 GPRIN3 GTF2IRD1	1.90e-04	173	136	5	4bc6d93716f093b460c8b047199db8cab5fea720
ToppCell	3'-GW_trimst-1-SmallIntestine-Epithelial-mature_enterocytic-Paneth\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VWA5B2 BNIP5 MARCHF9 SLCO4A1 BAIAP2L2	1.95e-04	174	136	5	b4483d7d9f22f09ed7fa0b72305434a47ccaade0
ToppCell	COVID-19-kidney-REN+Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	TBX3 MECOM DLC1 LZTS1 TMEM26	1.95e-04	174	136	5	8393f0b43c767839c1630bcb952d62b42efc788d
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 MAP1A MMP21 MPRIP DLC1	2.01e-04	175	136	5	910a075ccaf79de22338ecf321fa0a867f3d7d75
ToppCell	metastatic_Brain-T/NK_cells-Exhausted_Tfh\|metastatic_Brain / Location, Cell class and cell subclass	TMEM201 BRPF1 MARK4 PCIF1 GTPBP3	2.01e-04	175	136	5	b732c6a423c28856211002107d8c611dcfb6f265
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 MAP1A MMP21 MPRIP DLC1	2.01e-04	175	136	5	f0c2eb82e17e8aec2cfa5d83169178f409cc1abc
ToppCell	390C-Fibroblasts-Fibroblast-B_(Myofibroblast)\|390C / Donor, Lineage, Cell class and subclass (all cells)	COL6A3 TBX3 PLEKHA4 CERCAM CAP2	2.06e-04	176	136	5	852d3da0907fe87c0ef23d75a63ce07619cf0c54
ToppCell	droplet-Kidney-KIDNEY-30m-Endothelial-Pecam____kidney_capillary_endothelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBX3 DLC1 LIMCH1 TMEM26 MN1	2.06e-04	176	136	5	c4d9166e5bbb7ca544107db14e4374289f5de6bd
ToppCell	390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-\|390C / Donor, Lineage, Cell class and subclass (all cells)	COL6A3 TBX3 PLEKHA4 CERCAM CAP2	2.06e-04	176	136	5	d2df1e435996c51213e88270af9f928e9e09a6f5
ToppCell	droplet-Kidney-KIDNEY-30m-Endothelial-kidney_capillary_endothelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBX3 DLC1 LIMCH1 TMEM26 MN1	2.06e-04	176	136	5	d58ef51002ea50b3037636038214bbb7454cb503
ToppCell	facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l39\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CNNM2 TRARG1 PPARGC1B BCAR3 CAP2	2.11e-04	177	136	5	928118b0ed120ec01c7d753ce523ab609ac24e5f
ToppCell	cellseq2-Mesenchymal-Myocytic-Myocytic_1-Pericyte\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TBX3 CNNM2 LZTS1 GLI3 CDYL2	2.11e-04	177	136	5	68263456a3c93cd195b321b309ff59e156d732fe
ToppCell	cellseq2-Mesenchymal-Myocytic-Myocytic_1\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TBX3 CNNM2 LZTS1 GLI3 CDYL2	2.11e-04	177	136	5	e415e448c37adc102d766235e9953dec32c021f1
ToppCell	Control-Epithelial_alveolar-AT_1-Differentiating_AT1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 GPRIN3 PLEKHG4B AJAP1 LIMCH1	2.11e-04	177	136	5	9af14a056eb6d88c6f11b09f6d4c0d3448d647d5
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TBX3 CNNM2 SYNM DLC1 LZTS1	2.17e-04	178	136	5	185b44700f06ec58b3c09c80520502166c965fd6
ToppCell	droplet-Fat-SCAT-30m-Mesenchymal-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DRP2 FNDC1 KIAA1549L KANK4 LRP4	2.17e-04	178	136	5	5cf12927f0756c4d8a289fe4308d736382e6212e
ToppCell	TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6\|TCGA-Ovary / Sample_Type by Project: Shred V9	DRP2 FNDC1 DLC1 PCDHGA12 LZTS1	2.17e-04	178	136	5	142879e9393e721f9b05a6bb46995c9d6d713c95
ToppCell	metastatic_Brain-T/NK_cells-Exhausted_Tfh\|T/NK_cells / Location, Cell class and cell subclass	COL6A3 TMEM201 BRPF1 MARK4 GTPBP3	2.17e-04	178	136	5	9a3581a0158dfa5a1cc942f8c532afb5e38b272a
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-VLMC-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MAP1A CCDC85A TMEM26 MN1 CAP2	2.23e-04	179	136	5	381ac15d59f31bc613828bdcfbc9192b106b4d18
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MARCHF9 EIF4ENIF1 CELSR3 TLE1 OSBPL10	2.23e-04	179	136	5	a28a1de500a74c6dcc43481abf9ec0f7e7a300a9
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MECOM CCDC88C NPAP1 LIMCH1 BCAR3	2.29e-04	180	136	5	023ec0b080c8a5cd0f36e83c6b17d4be3c01edb5
ToppCell	droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____fenestrated_capillary_endothelial\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1A TRARG1 CCDC85A TRIM7 MARK4	2.29e-04	180	136	5	79c5725f02e038d0187f4a1e1591f2492538aa57
ToppCell	droplet-Kidney-nan-18m-Epithelial-Stroma____kidney_mesangial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 MAP1A TRARG1 SYNM CAP2	2.29e-04	180	136	5	b6f44fdedc33b7d93b0074e8e9c8cc32009d4c4d
ToppCell	droplet-Kidney-nan-3m-Mesenchymal-podocyte\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1A NTN3 PLEKHA4 FNDC1 MARK4	2.34e-04	181	136	5	0b1e7335648823b1d83bdfa878ccd44efe7bba9a
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SHROOM3 CNNM2 KCNH7 GPRIN3 GTF2IRD1	2.34e-04	181	136	5	e0abf2707d9e0aa942c657eef7d2cbcd02f060dd
Drug	Cyclosporin A [59865-13-3]; Down 200; 3.4uM; MCF7; HT_HG-U133A	SYNM CCDC85C MECOM DBP MAST2 MXD4 AJAP1 MARK4 HCFC1 MAST3	2.50e-07	194	135	10	4411_DN
Drug	Strophantine octahydrate [11018-89-6]; Down 200; 5.4uM; PC3; HT_HG-U133A	APC CCDC85C DBP PACS1 MIA2 MARK4 RNFT1 PWWP3A MN1	2.05e-06	190	135	9	6680_DN
Drug	Bretylium tosylate [61-75-6]; Down 200; 9.6uM; PC3; HT_HG-U133A	CNNM2 APC MAST2 RGS10 CCDC88C PACS1 KIAA1549L PCIF1 RNFT1	3.01e-06	199	135	9	6674_DN
Drug	Bumetanide [28395-03-1]; Down 200; 11uM; MCF7; HT_HG-U133A	APC TFAP2C RGS10 MIA2 CELSR3 GLI3 MARK4 PCIF1 HCFC1	3.01e-06	199	135	9	5542_DN
Drug	Cephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; PC3; HT_HG-U133A	MAP1A APC MXD4 CDK13 CEP135 PCIF1 RNFT1 CPSF7	2.12e-05	194	135	8	4242_DN
Drug	aspirin, USP; Up 200; 100uM; MCF7; HT_HG-U133A	DRP2 MECOM RGS10 NFKBIE CEP135 MAP3K9 MAPK8IP2 VCPIP1	2.36e-05	197	135	8	6924_UP
Drug	Berberine chloride [633-65-8]; Up 200; 10.8uM; PC3; HT_HG-U133A	EFCAB14 DBP TFAP2C MXD4 RGS10 CCDC88C TLE1 RNFT1	2.36e-05	197	135	8	7143_UP
Drug	Alfuzosin hydrochloride [81403-68-1]; Down 200; 9.4uM; MCF7; HT_HG-U133A	APC RGS10 MIA2 MAP1S PARD6A TLE1 LIMCH1 MAST3	2.45e-05	198	135	8	5242_DN
Drug	Maprotiline hydrochloride [10347-81-6]; Down 200; 12.8uM; PC3; HT_HG-U133A	CAMTA2 PACS1 CELSR3 MARK4 IL4R MAPK8IP2 CPEB1 CPSF7	2.63e-05	200	135	8	6676_DN
Drug	Sertaconazole nitrate [99592-39-9]; Up 200; 8uM; HL60; HT_HG-U133A	CNNM2 APC CRTC1 GRIN2C MXD4 BCAR3 HCFC1 AGAP2	2.63e-05	200	135	8	6128_UP
Drug	Apramycin [37321-09-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A	CNNM2 APC CDK13 BRPF1 PCIF1 PWWP3A LIMCH1 VCPIP1	2.63e-05	200	135	8	4959_DN
Drug	9alpha-fluorocortisone	PPRC1 CYP21A2	1.04e-04	3	135	2	CID003033949
Drug	2,4,5,2',5'-pentachlorobiphenyl	ZMYND15 COL6A3 MYO19 CYP21A2 CYP27B1 CCDC85C SLCO4A1 GPRIN3 GRIN2C MAP7 TFAP2C FNDC1 AJAP1 CELSR3 PTPRJ PLCH2 FRMPD3 HCFC1 IL4R CAP2 AGAP2	1.16e-04	1441	135	21	ctd:C009828
Drug	radicicol; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA	SYNM APC MXD4 NFKBIE RNFT1 LIMCH1 CPEB1	1.38e-04	189	135	7	836_UP
Drug	Carbarsone [121-59-5]; Down 200; 15.4uM; MCF7; HT_HG-U133A	APC CCDC85C MAST2 TLE1 GLI3 RNFT1 LIMCH1	1.52e-04	192	135	7	4110_DN
Drug	Furosemide [54-31-9]; Down 200; 12uM; MCF7; HT_HG-U133A	CNNM2 CELSR3 GLI3 MARK4 HCFC1 MAST3 VCPIP1	1.57e-04	193	135	7	3197_DN
Drug	geldanamycin; Down 200; 1uM; MCF7; HT_HG-U133A	PPRC1 TFAP2C PARD6A BRPF1 RNFT1 HCFC1 MAST3	1.57e-04	193	135	7	1653_DN
Drug	Harmaline hydrochloride dihydrate [6027-98-1]; Up 200; 14uM; MCF7; HT_HG-U133A	PACS1 MARK4 LRP4 HCFC1 IL4R MAST3 AGAP2	1.67e-04	195	135	7	2805_UP
Drug	Nefopam hydrochloride [23327-57-3]; Down 200; 13.8uM; MCF7; HT_HG-U133A	APC CRTC1 CAMTA2 RGS10 PACS1 CDK13 MARK4	1.67e-04	195	135	7	2317_DN
Drug	Minocycline hydrochloride [13614-98-7]; Down 200; 8uM; PC3; HT_HG-U133A	CRTC1 MAP7 TFAP2C MIA2 TLE1 HCFC1 IL4R	1.67e-04	195	135	7	5077_DN
Drug	Bumetanide [28395-03-1]; Down 200; 11uM; PC3; HT_HG-U133A	CNNM2 MAP1A APC PACS1 MIA2 DENND4B MARK4	1.67e-04	195	135	7	5117_DN
Drug	Benzathine benzylpenicillin [5928-84-7]; Up 200; 4.2uM; MCF7; HT_HG-U133A	MAP1A MXD4 DLC1 CDK13 TLE1 LIMCH1 MAST3	1.67e-04	195	135	7	7359_UP
Drug	Beta-sistosterol [83-46-5]; Down 200; 9.6uM; PC3; HT_HG-U133A	CRTC1 TFAP2C MXD4 PACS1 DLC1 MARK4 LRP4	1.67e-04	195	135	7	4073_DN
Drug	Oxolinic acid [14698-29-4]; Down 200; 15.4uM; PC3; HT_HG-U133A	APC CAMTA2 MAP7 KIAA1549L PARD6A RNFT1 MAP3K9	1.72e-04	196	135	7	2103_DN
Drug	Pantothenic acid calcium salt monohydrate [63409-48-3]; Down 200; 8uM; MCF7; HT_HG-U133A	DBP MAST2 PACS1 PARD6A GLI3 LIMCH1 BCAR3	1.72e-04	196	135	7	4775_DN
Drug	Sulfadoxine [2447-57-6]; Down 200; 12.8uM; MCF7; HT_HG-U133A	MYO19 CRTC1 TFAP2C RGS10 PACS1 PCIF1 RNFT1	1.72e-04	196	135	7	3547_DN
Drug	Oxprenolol hydrochloride [6452-73-9]; Down 200; 13.2uM; MCF7; HT_HG-U133A	APC CRTC1 TFAP2C WAC MAP1S BRPF1 MARK4	1.72e-04	196	135	7	3568_DN
Drug	PHA-00851261E [724719-49-7]; Down 200; 10uM; MCF7; HT_HG-U133A	MAP1A APC MAST2 RGS10 DLC1 MARK4 VCPIP1	1.72e-04	196	135	7	3965_DN
Drug	Pyrithyldione [77-04-3]; Down 200; 24uM; MCF7; HT_HG-U133A	APC MAST2 RGS10 CDK13 LIMCH1 GTPBP3 IL4R	1.72e-04	196	135	7	3482_DN
Drug	2-propylpentanoic acid; Down 200; 50uM; MCF7; HT_HG-U133A_EA	SLCO4A1 EIF4ENIF1 CELSR3 PARD6A GLI3 MARK4 HCFC1	1.72e-04	196	135	7	1002_DN
Drug	Clorsulon [60200-06-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A	DIDO1 CELSR3 TLE1 CEP135 LIMCH1 HCFC1 AGAP2	1.72e-04	196	135	7	2884_UP
Drug	Methiazole; Down 200; 15uM; PC3; HT_HG-U133A	APC MAST2 PACS1 MARK4 MAP3K9 PWWP3A IL4R	1.78e-04	197	135	7	4532_DN
Drug	Piperidolate hydrochloride [129-77-1]; Up 200; 11.2uM; MCF7; HT_HG-U133A	CRTC1 PDZD7 MXD4 RGS10 MAP1S MARK4 MAPK8IP2	1.78e-04	197	135	7	6772_UP
Drug	Diethylcarbamazine citrate [1642-54-2]; Down 200; 10.2uM; PC3; HT_HG-U133A	CNNM2 MAP7 PACS1 PARD6A MAP3K9 MAST3 VCPIP1	1.78e-04	197	135	7	5066_DN
Drug	Rauwolscine hydrochloride [6211-32-1]; Down 200; 10.2uM; PC3; HT_HG-U133A	CRTC1 MIA2 MARK4 CEP135 IL4R MAST3 CPEB1	1.78e-04	197	135	7	5800_DN
Drug	Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A	TBX3 CCDC85C MXD4 PARD6A TLE1 MARK4 HCFC1	1.78e-04	197	135	7	4730_DN
Drug	LY 294002; Down 200; 0.1uM; HL60; HT_HG-U133A	APC MXD4 MAP1S MARK4 IL4R MAST3 CPSF7	1.78e-04	197	135	7	1157_DN
Drug	Pirenperone [ 75444-65-4]; Up 200; 10.2uM; PC3; HT_HG-U133A	CNNM2 APC TFAP2C MXD4 DLC1 MIA2 TLE1	1.78e-04	197	135	7	4679_UP
Drug	Bumetanide [28395-03-1]; Down 200; 11uM; MCF7; HT_HG-U133A	APC CCDC85C CAMTA2 MAST2 RGS10 MARK4 MAP3K9	1.78e-04	197	135	7	7440_DN
Drug	Alfadolone acetate [23930-37-2]; Up 200; 10.2uM; PC3; HT_HG-U133A	PPRC1 CCDC85C DBP TFAP2C MIA2 RNFT1 PWWP3A	1.78e-04	197	135	7	7262_UP
Drug	Ganciclovir [82410-32-0]; Down 200; 15.6uM; PC3; HT_HG-U133A	CNNM2 CCDC85C DIDO1 PACS1 PARD6A RNFT1 HCFC1	1.78e-04	197	135	7	6289_DN
Drug	Convolamine hydrochloride [500-56-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A	DIDO1 CAMTA2 PARD6A BRPF1 IL4R MAST3 VCPIP1	1.78e-04	197	135	7	7230_DN
Drug	haloperidol; Down 200; 10uM; PC3; HT_HG-U133A	CCDC85C MAP7 MXD4 RGS10 CCDC88C DENND4B HCFC1	1.83e-04	198	135	7	1244_DN
Drug	Evoxine [522-11-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A	APC CCDC85C MXD4 CCDC88C PWWP3A HCFC1 VCPIP1	1.83e-04	198	135	7	4704_DN
Drug	Carteolol hydrochloride [51781-21-6]; Up 200; 12.2uM; HL60; HT_HG-U133A	CRTC1 MAST2 MXD4 CDK13 TLE1 CEP135 IL4R	1.83e-04	198	135	7	1340_UP
Drug	Dioxybenzone [131-53-3]; Down 200; 16.4uM; MCF7; HT_HG-U133A	SLCO4A1 CRTC1 RGS10 CELSR3 MARK4 HCFC1 VCPIP1	1.83e-04	198	135	7	6478_DN
Drug	Novobiocin sodium salt [1476-53-5]; Up 200; 6.4uM; MCF7; HT_HG-U133A	COL6A3 MECOM RGS10 PARD6A MARK4 CEP135 AGAP2	1.83e-04	198	135	7	4392_UP
Drug	Oxolinic acid [14698-29-4]; Down 200; 15.4uM; PC3; HT_HG-U133A	CNNM2 CCDC85C MAST2 TFAP2C PACS1 MIA2 MARK4	1.83e-04	198	135	7	5094_DN
Drug	Tranexamic acid [1197-18-8]; Down 200; 25.4uM; PC3; HT_HG-U133A	CNNM2 CCDC85C MAST2 RGS10 KIAA1549L PARD6A CPSF7	1.83e-04	198	135	7	2085_DN
Drug	Hydroquinine hydrobromide hydrate [304695-81-6]; Down 200; 9.4uM; MCF7; HT_HG-U133A	CYP27B1 APC CCDC85C MAST2 RGS10 PACS1 CELSR3	1.83e-04	198	135	7	2767_DN
Drug	Pepstatin A [26305-03-3]; Down 200; 5.8uM; MCF7; HT_HG-U133A	APC CCDC85C CRTC1 PACS1 RNFT1 HCFC1 CPSF7	1.83e-04	198	135	7	3264_DN
Drug	Mefexamide hydrochloride [3413-64-7]; Up 200; 12.6uM; MCF7; HT_HG-U133A	TBX3 MAP1A RGS10 HOXA9 MAP1S MARK4 HCFC1	1.83e-04	198	135	7	2284_UP
Drug	Danazol [17230-88-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A	CRTC1 DLC1 AJAP1 MARK4 LIMCH1 IL4R ECE2	1.83e-04	198	135	7	1538_UP
Drug	Repaglinide [135062-02-1]; Down 200; 8.8uM; MCF7; HT_HG-U133A	APC MXD4 CCDC88C AJAP1 MAP1S PARD6A MAP3K9	1.89e-04	199	135	7	3558_DN
Drug	Cromolyn disodium salt [15826-37-6]; Up 200; 7.8uM; PC3; HT_HG-U133A	MAP1A APC CRTC1 RGS10 CELSR3 MARK4 NPAP1	1.89e-04	199	135	7	5754_UP
Drug	chlorpromazine hydrochloride; Up 200; 1uM; HL60; HT_HG-U133A	CNNM2 CRTC1 MAP7 DLC1 TLE1 PLCH2 AGAP2	1.89e-04	199	135	7	2677_UP
Drug	Piperacillin sodium salt [59703-84-3]; Down 200; 7.4uM; MCF7; HT_HG-U133A	APC CCDC85C CRTC1 MXD4 MIA2 CDK13 MARK4	1.89e-04	199	135	7	3845_DN
Drug	Trichlorfon [52-68-6]; Up 200; 15.6uM; PC3; HT_HG-U133A	CRTC1 MAP7 RGS10 MIA2 CDK13 IL4R CPEB1	1.89e-04	199	135	7	7287_UP
Drug	Bretylium tosylate [61-75-6]; Up 200; 9.6uM; HL60; HT_HG-U133A	MAP1A CCDC85C MAP7 MXD4 RGS10 PPARGC1B TLE1	1.95e-04	200	135	7	3057_UP
Drug	Noscapine [128-62-1]; Up 200; 9.6uM; PC3; HT_HG-U133A	CCDC85C MAP7 MXD4 CELSR3 MARK4 LRP4 HCFC1	1.95e-04	200	135	7	5851_UP
Drug	Medrysone [2668-66-8]; Up 200; 11.6uM; MCF7; HT_HG-U133A	APC CRTC1 MAST2 PACS1 MIA2 TLE1 MARK4	1.95e-04	200	135	7	3403_UP
Disease	Syndactyly Cenani Lenz type	APC LRP4	2.08e-05	2	135	2	C1859309
Disease	sphingomyelin measurement	ZMYND15 PABPC4 CYP27B1 BUD13 CAMTA2 LZTS1 PCIF1 KANK4	4.43e-05	278	135	8	EFO_0010118
Disease	Colorectal cancer	APC DLC1 PTPRJ	2.53e-04	27	135	3	cv:C0346629
Disease	COLORECTAL CANCER	APC DLC1 PTPRJ	2.53e-04	27	135	3	114500
Disease	Neoplasm of the large intestine	APC DLC1 PTPRJ	2.53e-04	27	135	3	cv:C0009404
Disease	brain disease (implicated_via_orthology)	MYCBP2 TIAM2	3.08e-04	6	135	2	DOID:936 (implicated_via_orthology)
Disease	tumor necrosis factor ligand superfamily member 6, soluble form measurement	CELSR3 BSN	4.30e-04	7	135	2	EFO_0020797
Disease	Polysyndactyly	GLI3 LRP4	4.30e-04	7	135	2	C0265553
Disease	daytime rest measurement	MYCBP2 APC IRAK1BP1 CCDC88C LZTS1 ECE2 CPEB1	4.33e-04	295	135	7	EFO_0007828
Disease	ovarian carcinoma	MECOM TFAP2C DLC1 TLE1 GLI3 OSBPL10 TTLL10	7.13e-04	321	135	7	EFO_0001075
Disease	Colon Carcinoma	ERBB3 PTPRJ	7.32e-04	9	135	2	C0699790
Disease	Odontome	TBX3 LRP4	9.13e-04	10	135	2	C0524730
Disease	Tooth Abnormalities	TBX3 LRP4	9.13e-04	10	135	2	C0040427
Disease	stromal cell-derived factor 1 alpha measurement	CYP21A2 GPRIN3 ACSF3	1.01e-03	43	135	3	EFO_0008293
Disease	chronic obstructive pulmonary disease	COL6A3 ERBB3 PABPC4 MECOM CRTC1 PPARGC1B DLC1 TLE1 SSH2 MN1	1.29e-03	688	135	10	EFO_0000341
Disease	FEV/FEC ratio	COL6A3 ERBB3 PABPC4 CCDC85C MECOM CRTC1 GTF2IRD1 TFAP2C FAM83H PPARGC1B DLC1 CTAGE1 SSH2 MN1	1.53e-03	1228	135	14	EFO_0004713
Disease	cortical thickness	VWA5B2 ERBB3 SHROOM3 CNNM2 MYCBP2 MECOM MAST2 DLC1 CBY2 GLI3 LRP4 SSH2 CPEB1	1.83e-03	1113	135	13	EFO_0004840
Disease	endometrial carcinoma	CCDC85A DLC1 TLE1 CTAGE1	1.84e-03	113	135	4	EFO_1001512
Disease	Drug habituation	TIAM2 PACS1 LIMCH1 BCAR3	1.96e-03	115	135	4	C0013170
Disease	Drug abuse	TIAM2 PACS1 LIMCH1 BCAR3	1.96e-03	115	135	4	C0013146
Disease	Prescription Drug Abuse	TIAM2 PACS1 LIMCH1 BCAR3	1.96e-03	115	135	4	C4316881
Disease	Substance-Related Disorders	TIAM2 PACS1 LIMCH1 BCAR3	1.96e-03	115	135	4	C0236969
Disease	Drug Use Disorders	TIAM2 PACS1 LIMCH1 BCAR3	1.96e-03	115	135	4	C0013222
Disease	Drug Dependence	TIAM2 PACS1 LIMCH1 BCAR3	1.96e-03	115	135	4	C1510472
Disease	Substance Dependence	TIAM2 PACS1 LIMCH1 BCAR3	1.96e-03	115	135	4	C0038580
Disease	Substance Use Disorders	TIAM2 PACS1 LIMCH1 BCAR3	1.96e-03	115	135	4	C0038586
Disease	Organic Mental Disorders, Substance-Induced	TIAM2 PACS1 LIMCH1 BCAR3	1.96e-03	115	135	4	C0029231
Disease	IGFBP-3 measurement	TREX1 ERBB3 MPRIP	1.96e-03	54	135	3	EFO_0004626
Disease	Substance abuse problem	TIAM2 PACS1 LIMCH1 BCAR3	2.02e-03	116	135	4	C0740858
Disease	Situs ambiguus	SHROOM3 MMP21	2.10e-03	15	135	2	C0266642
Disease	alkaline phosphatase measurement	CNNM2 MAP1A CYP21A2 S1PR2 ZFAND4 WAC PTPRJ GLI3 MARK4 PITX3 PCIF1 CDYL2	2.47e-03	1015	135	12	EFO_0004533
Disease	Stomach Neoplasms	TBX3 ERBB3 APC TFAP2C DLC1 GLI3	2.51e-03	297	135	6	C0038356
Disease	Malignant neoplasm of stomach	TBX3 ERBB3 APC TFAP2C DLC1 GLI3	2.64e-03	300	135	6	C0024623
Disease	Benign neoplasm of stomach	ERBB3 APC	2.70e-03	17	135	2	C0153943
Disease	Neoplasm of uncertain or unknown behavior of stomach	ERBB3 APC	2.70e-03	17	135	2	C0496905
Disease	Lipidemias	APC PPARGC1B	2.70e-03	17	135	2	C1706412
Disease	Carcinoma in situ of stomach	ERBB3 APC	2.70e-03	17	135	2	C0154060
Disease	Hyperlipidemia	APC PPARGC1B	2.70e-03	17	135	2	C0020473
Disease	free cholesterol in HDL measurement	PABPC4 BUD13 PCIF1	2.78e-03	61	135	3	EFO_0022264
Disease	triglycerides:total lipids ratio, intermediate density lipoprotein measurement	SHROOM3 CTAGE1 PCIF1 LRP4	2.80e-03	127	135	4	EFO_0008595, EFO_0020947
Disease	total lipids in HDL measurement	PABPC4 BUD13 PCIF1	3.04e-03	63	135	3	EFO_0022307
Disease	coronary artery disease	COL6A3 SHROOM3 CNNM2 KCNH7 MECOM BUD13 FNDC1 DLC1 MAP1S PTPRJ MARK4 CEP135 BSN	3.34e-03	1194	135	13	EFO_0001645
Disease	magnesium measurement	SHROOM3 MECOM DLC1	3.47e-03	66	135	3	EFO_0004845
Disease	venous thromboembolism, fibrinogen measurement	CYP21A2 PTPRJ LRP4	3.62e-03	67	135	3	EFO_0004286, EFO_0004623
Disease	citrulline measurement	CYP21A2 MECOM	3.74e-03	20	135	2	EFO_0009777
Disease	diabetes mellitus	MYCBP2 CRTC1 TLE1	3.78e-03	68	135	3	EFO_0000400
Disease	Stomach Carcinoma	ERBB3 APC	4.12e-03	21	135	2	C0699791
Disease	cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement	CYP21A2 PABPC4 BUD13 PCIF1	4.39e-03	144	135	4	EFO_0004611, EFO_0020943
Disease	Splenomegaly	APC MECOM	4.52e-03	22	135	2	C0038002
Disease	Primary microcephaly	TUBGCP6 CEP135	4.52e-03	22	135	2	C0431350

Protein segments in the cluster

Peptide	Gene	Start	Entry
SPPERSCHSLSERGL	C2orf16	1616	Q68DN1
VSGSSERCPRPVSLH	ERBB3	1071	P21860
DPSPLRGARHDSDTS	BUD13	161	Q9BRD0
SPPRRARHGSSDISS	BUD13	226	Q9BRD0
LSQDRTPHGTSRLAP	TFAP2C	366	Q92754
SRSLIHDAPGPAASR	CATSPER1	331	Q8NEC5
SSCDRLTDPHRAPSD	CTAGE1	546	Q96RT6
DLLSSRSPLAEHRPD	BCAR3	26	O75815
HASLRLLSDPRSGEP	GTPBP3	76	Q969Y2
GNRPSSSDRHLIPVA	AJAP1	386	Q9UKB5
PDSLGRLPLSVAHSR	CAMTA2	786	O94983
SLPSSPNVGHRELRA	AGAP2	611	Q99490
LLHTAPVARSDRSAP	ACSF3	31	Q4G176
SRTGSLTDEPADPAR	CDAN1	281	Q8IWY9
LSPLGGRDDSPVSHR	CDK13	316	Q14004
PSSHRLLRTEPPDSD	EFCAB14	26	O75071
SDDVTPLRLSGRHFP	PGBD4	511	Q96DM1
RKRPPSDIHDSDGSS	RGS10	11	O43665
PPRAHSRDSSDSADG	CPSF7	186	Q8N684
DRGTPPLSTETHISL	PCDHGA12	426	O60330
ESRPASDGSLQHARP	MECOM	806	Q03112
HSARRSLADIPGPST	CYP27B1	31	O15528
SLSGVAPLPRSLHSA	HCFC1	246	P51610
TLRHLAPTGSECPDR	PABPC4	461	Q13310
TERSRAGSPTAPVHD	PTPRJ	296	Q12913
SLVDLSTPGHRRGSP	OR10AC1	81	Q8NH08
LPDASASPLSPHRRA	MPRIP	356	Q6WCQ1
ISATRGLSPTDAPHA	GLI3	216	P10071
TRHEADSSPRGDPES	HAX1	241	O00165
RETLPGLRHPLSSTQ	IRAK1BP1	31	Q5VVH5
PLGPDSTRHTTLSLL	MXD4	81	Q14582
GAERSSRPDTLLSPE	MAP1A	2396	P78559
PESHRSPAEGSERLS	MAP1S	641	Q66K74
LPRSGAILHSSPESA	LZTS1	131	Q9Y250
LHGSPSIHSADPDRR	MAP7	166	Q14244
EERSGAHSSASPPRS	NELFE	171	P18615
SDGLHPVITPSRASE	MUC20	351	Q8N307
LLRRLHPCTSSGPDS	MYO19	671	Q96H55
IRHPSLPDSSLSTVG	KCNH7	1166	Q9NS40
LRTLSSLRAGPSEPH	NFKBIE	81	O00221
SPSSDPGIEADLRSR	MAPK8IP2	221	Q13387
RSPRRTSLDSGHSDP	JPH4	156	Q96JJ6
PEDRSRGEHSSTLPA	BSN	971	Q9UPA5
EASRSPSRAHSPGLL	BAIAP2L2	221	Q6UXY1
GATRRSLDDLSAPPH	CCDC85C	241	A6NKD9
RSSPTHDTPSCRDDL	CCDC88C	1681	Q9P219
PSSHSLARERTPLVG	CCDC88C	1851	Q9P219
DPPASSSGAPHLRAR	GJD4	351	Q96KN9
SRLESLSAESHRPPG	CAP2	16	P40123
LALPHRTTRPSSISG	CYP21A2	361	P08686
DPHSPARFRVLGTLS	ECE2	771	P0DPD6
SLFHSRDRSDLEPSP	MMP21	26	Q8N119
GPHPGRRLDSALSES	PDZD7	401	Q9H5P4
PLSARRGDCPTLDTH	HOXA9	136	P31269
GSASRETLLPSHPPR	TUBGCP6	996	Q96RT7
SHPPRRAALEEGSSQ	TUBGCP6	1006	Q96RT7
RGPALSAEHTSSLVP	KIAA1549L	161	Q6ZVL6
LGQLRPPDARSSSHS	MARCHF9	321	Q86YJ5
PPDARSSSHSGREVV	MARCHF9	326	Q86YJ5
SERSPDLGHSTQIPR	PACS1	531	Q6VY07
CRHPGTRSSLPSLDD	PARD6A	311	Q9NPB6
DPRRAHSPALLTSPG	NTN3	71	O00634
SLGREESRAPSPLLH	CBY2	206	Q8NA61
RHGLATPPLSSTLRS	CEP135	1116	Q66GS9
LLLPRSHSDPGITTS	FAM189B	486	P81408
TLDHRSLLSDTNPGP	ATMIN	606	O43313
GLDREPPRSPQSSHL	IL4R	656	P24394
HSPDSLPLRSSGRQA	KDM1B	16	Q8NB78
GHRPSTSSSLDPEDL	BNIP5	481	P0C671
HGSPREEASLLSHSP	PCIF1	6	Q9H4Z3
HRPAGVSPLSLSTEA	CRTC1	306	Q6UUV9
SPRAPTGSRADSLHL	FRMPD3	1066	Q5JV73
SPSSVLRDRSSVHPG	FNDC1	676	Q4ZHG4
LAPLRTLSGTPEVHS	COL6A3	621	P12111
EDPRNLHSAGRSSSP	DIDO1	1701	Q9BTC0
SSTHIRSLEPPAGLT	C17orf80	511	Q9BSJ5
GSLEHLPRARGTSPE	CCDC85A	346	Q96PX6
SHSLAPPSGERSRLA	MARK4	546	Q96L34
RDSSPSRDFLPALGS	MAST2	1086	Q6P0Q8
NSIGARHSTPRPLDA	MAST3	846	O60307
SLLHPRERPGSTASE	DENND4B	1096	O75064
PATLLHSRASEEPGL	KANK4	166	Q5T7N3
HRAGLTSRDTPSPVD	DBP	181	Q10586
DHLSDLISSLRISPP	CPEB1	196	Q9BZB8
SGPELDSAPRTARTA	CELSR3	241	Q9NYQ7
VPSSASREVRHGSDP	FAM83H	511	Q6ZRV2
TLRSPRLDLTGSSGH	CERCAM	571	Q5T4B2
GRSLPRSSLEHGSDV	GTF2IRD1	111	Q9UHL9
SAPSSAAGRDLIHTP	GPRIN3	111	Q6ZVF9
PGHHLLPLRSSSSLE	S1PR2	321	O95136
RGAPLIRVHSSPVSS	SPACA3	6	Q8IXA5
ARSPALSLSDAGTPH	PITX3	11	O75364
ESGTSATTHEARPRP	PPRC1	736	Q5VV67
SHRRTPSDGALKPET	MAP3K9	911	P80192
LRHSSPITDREPAFG	DRP2	756	Q13474
LSPPRHGRDDSFDSL	LIMCH1	191	Q9UPQ0
SCDRLTDPHRAPSDT	MIA2	1186	Q96PC5
LPSSSGSDSHSLEPR	MN1	206	Q10571
SSLPRGDVLGSSRPH	PWWP3A	136	Q2TAK8
LLASRGFPRDPSTES	RTL1	1016	A6NKG5
AIPLRGSPVTSDDSH	TMEM26	351	Q6ZUK4
GRLDKASPDSRHSPA	TBX3	426	O15119
LADSSRTLRHIAPGP	SYNM	1441	O15061
RVSRASSPEGRHLPS	PLEKHA4	561	Q9H4M7
RAPHKESTLPRSGSS	CHCHD6	61	Q9BRQ6
SRGPCSDRTPSIRHA	PPARGC1B	876	Q86YN6
PSSAHVGLRSPEASA	SHROOM3	961	Q8TF72
VGLRSPEASASASPH	SHROOM3	966	Q8TF72
GSSLLRHPSPELSRL	MYCBP2	3511	O75592
GHEPVSPRSLQRSSS	WAC	506	Q9BTA9
APLSRDASPPGRAHS	NPAP1	26	Q9NZP6
PGHISLRRENSSDSP	DLC1	846	Q96QB1
APSSRSRSLTLLPHG	OSBPL10	181	Q9BXB5
PGSLRSAAHSPLDTS	SLCO4A1	41	Q96BD0
GSARRLPALSHSEGE	BRPF1	451	P55201
LEHRPSQRSSSPVGL	EIF4ENIF1	941	Q9NRA8
HDIARSHSESPSRLP	APC	2526	P25054
SHSESPSRLPINRSG	APC	2531	P25054
SRGPSVEKLSHRPSD	CDYL2	81	Q8N8U2
PRPCGLNHSDSLSRS	CNNM2	751	Q9H8M5
LSLPTPPSASGHERR	RNFT1	6	Q5M7Z0
HRDREPGTSNSLLVP	TLE1	191	Q04724
TSPERSPLSCGHLSR	TRIM7	446	Q9C029
VPEARRGSSADSLPS	TIAM2	211	Q8IVF5
RGSSADSLPSHRPSP	TIAM2	216	Q8IVF5
DSLPSHRPSPTDSRL	TIAM2	221	Q8IVF5
HRPSPTDSRLRSSKG	TIAM2	226	Q8IVF5
DHPTSILSSPEDRGS	SSH2	1091	Q76I76
EDAHLPRLVSRTPGT	ILDR2	506	Q71H61
SRSLSSPSGLHPAEE	PLEKHG4B	781	Q96PX9
SLDSHAAGRPPARPS	PLCH2	906	O75038
LHENSGSPETSRSLP	RIPK2	351	O43353
RGTDELHSPSSPRVE	TP53INP1	146	Q96A56
HPSLPASGRSAEVTL	TAPBP	386	O15533
SSSGSLRHRRPLISP	TMEM201	516	Q5SNT2
SGNPHLDPRARETSV	VCPIP1	1036	Q96JH7
LHPSGLPELESRARS	PLEKHH1	356	Q9ULM0
SSRELPSRPDGVLHV	VWA5B2	136	Q8N398
SPLRSSSALGDHLEP	ZNF445	171	P59923
SEGHLEAPLPRSPSR	TRARG1	66	Q8IXB3
SRTTLPASGHLPISR	TMC2	861	Q8TDI7
PSSGSTAPSRHRLLR	ZFAND4	256	Q86XD8
ALERASSPSEHGPRK	TREX1	161	Q9NSU2
ARVSGTIPASRLHPA	TTLL10	36	Q6ZVT0
LHREVRSTPLTATPG	VTI1B	91	Q9UEU0
FSRHPRGNTPSLSLL	ZMYND15	416	Q9H091
VHTAATPERRGSLPD	LRP4	1876	O75096
CGRHLSASERPLSPA	GRIN2C	1011	Q14957